Related Experiment Video

Updated: Jun 11, 2026

Assay Development for High-Throughput Drug Screening Against Mycobacteria
07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

FtsZ inhibition: a promising approach for antistaphylococcal therapy

Parminder Singh1, Dulal Panda

  • 1Department of Biosciences and Bioengineering, Indian Institute of Technology, Bombay, India.

Drug News & Perspectives
|July 7, 2010
PubMed

Insights

Staphylococcus infections are a growing concern due to antibiotic resistance. Targeting the bacterial FtsZ protein offers a promising new strategy for developing novel antistaphylococcal therapies.

Area of Science:

  • Microbiology
  • Bacteriology
  • Drug Discovery

Background:

  • Staphylococcus species cause significant human and animal diseases.
  • Emergence of antibiotic-resistant strains (e.g., MRSA, VRSA) necessitates novel therapeutic targets.
  • FtsZ, a bacterial cytoskeleton protein, is crucial for cell division.

Purpose of the Study:

  • To review the assembly dynamics of the FtsZ protein and its role in bacterial cell division.
  • To highlight FtsZ as a potential drug target for combating Staphylococcus infections.

Main Methods:

  • Review of existing literature on FtsZ assembly, regulation, and inhibition.
  • Discussion of FtsZ-associated proteins and their role in Z-ring formation.
  • Analysis of FtsZ inhibitors, such as PC-190723, and their mechanism of action.

Main Results:

  • FtsZ forms a dynamic Z-ring essential for bacterial cell division.
  • Regulation of FtsZ assembly involves multiple accessory proteins.
  • Inhibitors targeting FtsZ can disrupt Staphylococcus cell division.

Conclusions:

  • FtsZ is a validated target for antibacterial drug development.
  • Targeting FtsZ offers a potential strategy against resistant Staphylococcus strains.
  • Further research into FtsZ inhibitors could lead to new antistaphylococcal treatments.

More Related Videos

Isolation of Lipoprotein Particles from Chicken Egg Yolk for the Study of Bacterial Pathogen Fatty Acid Incorporation into Membrane Phospholipids11:59

Isolation of Lipoprotein Particles from Chicken Egg Yolk for the Study of Bacterial Pathogen Fatty Acid Incorporation into Membrane Phospholipids

Published on: May 15, 2019

Deferred Growth Inhibition Assay to Quantify the Effect of Bacteria-derived Antimicrobials on Competition07:42

Deferred Growth Inhibition Assay to Quantify the Effect of Bacteria-derived Antimicrobials on Competition

Published on: September 3, 2016

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...